Sector
PharmaceuticalsOpen
₹1,789.8Prev. Close
₹1,792.3Turnover(Lac.)
₹5,368.44Day's High
₹1,801.8Day's Low
₹1,77652 Week's High
₹2,220.9552 Week's Low
₹1,277.8Book Value
₹612.12Face Value
₹1Mkt Cap (₹ Cr.)
29,349.71P/E
26.97EPS
66.14Divi. Yield
1.016 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
22 May 2024
12:00 AM
AGM
Announcement Date: 22 May, 2024
The receipt of the EIR marks the formal closure of the US health regulator’s pre-approval inspection, which was conducted between February 19 and February 25, 2025.
Here are some of the stocks that may see significant price movement today: Hindustan Aeronautics, Gland Pharma, REC, etc.
Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.
Gland Pharma net profit was at ₹186.5 crore as against ₹192.4 crore in the year-ago quarter of FY24.
Gland Pharma has secured exclusive rights as the first-to-file sponsor of this generic product. This makes it eligible for 180 days of marketing exclusivity in the US
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 16.47 | 16.47 | 16.51 | 16.36 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 8,978.82 | 7,936.83 | 7,141.72 | 5,886.93 |
Net Worth | 8,995.29 | 7,953.3 | 7,158.23 | 5,903.29 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2017 |
|---|---|---|---|
Revenue | 4,400.7 | 3,462.87 | 1,479.17 |
yoy growth (%) | 27.08 | 134.1 | |
Raw materials | -2,109.21 | -1,491.87 | -509.73 |
As % of sales | 47.92 | 43.08 | 34.46 |
Employee costs | -338.56 | -311.36 | -153.41 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2017 |
|---|---|---|---|
Profit before tax | 1,619.04 | 1,334.85 | 578.01 |
Depreciation | -110.29 | -98.78 | -74.14 |
Tax paid | -406.88 | -337.84 | -164.28 |
Working capital | 496.99 | 3,455.68 | |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2017 |
|---|---|---|---|
Growth matrix (%) | |||
Revenue growth | 27.08 | 134.1 | |
Op profit growth | 16 | 108.36 | |
EBIT growth | 21.37 | 128.99 | |
Net profit growth | 21.57 | 140.98 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 5,616.5 | 5,664.72 | 3,624.6 | 4,400.71 | 3,462.88 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 5,616.5 | 5,664.72 | 3,624.6 | 4,400.71 | 3,462.88 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 213.61 | 170.24 | 240.46 | 223.94 | 134.78 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
Yiu Kwan Stanley Lau
Managing Director & CEO
SRINIVAS SADU
Non-Exec & Non-Independent Dir
UDO JAHANNES VETTER
Independent Director
C S N Murthy
Independent Director
ESSAJI GOOLAM VAHANVATI
Independent Director
Naina Lal Kidwai
Non-Exec & Non-Independent Dir
Jia Ai (Allen) Zhang
Non Executive Director
Wenjie Zhang
Additional Director
Wei Huang
Sy No 143-148 150&151 Nr Gandi,
X Roads D P Pally Dundigal,
Telangana - 500043
Tel: 91-40-30510999
Website: http://www.glandpharma.com
Email: [email protected]
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: [email protected]
Summary
Gland Pharma Limited was incorporated as Gland Pharma Private Limited, a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pr...
Read More
Reports by Gland Pharma Ltd
What is the Gland Pharma Ltd share price today?
What is the Market Cap of Gland Pharma Ltd?
What is the PE and PB ratio of Gland Pharma Ltd?
What is the 52 Week High and Low of Gland Pharma Ltd?
What is the CAGR of Gland Pharma Ltd?
What is the shareholding pattern of Gland Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
